# Neonatal hyperthyroidism with myocardial injury: a case report

**Authors:** Tian Junhua, Jiang Qiuyan, Liu Ranfeng

PMC · DOI: 10.3389/fped.2026.1767859 · Frontiers in Pediatrics · 2026-02-19

## TL;DR

A newborn with neonatal hyperthyroidism showed severe symptoms and myocardial injury, but recovered after treatment with methimazole and propranolol.

## Contribution

This case report highlights the importance of timely diagnosis and treatment of neonatal hyperthyroidism to prevent serious complications.

## Key findings

- Neonatal hyperthyroidism was diagnosed after persistent symptoms and elevated myocardial injury markers.
- Treatment with methimazole and propranolol led to rapid resolution of symptoms.
- Early diagnosis and intervention are critical to prevent complications in neonatal hyperthyroidism.

## Abstract

Neonatal hyperthyroidism (NH) is a rarely reported condition, but inappropriate treatment can have serious consequences. Early diagnosis, treatment, and follow-up are, therefore, essential. We present the case of a male newborn who was admitted to the Pediatrics Department 24 min after birth due to prematurity, presenting with tachypnea and grunting for 20 min. Subsequently, the infant developed increased respiratory rate, tachycardia, crying, and irritability. Bilateral periorbital edema and hyperdynamic heart sounds were also noted. Myocardial injury markers were significantly elevated, indicating myocardial injury. Following treatment with dopamine and dobutamine, the heart rate decreased, but crying, irritability, and periorbital edema persisted. Further history-taking led to a diagnosis of NH with neonatal goiter. The infant was started on oral methimazole and propranolol. Three days after initiation of therapy, the symptoms resolved rapidly, and the patient was discharged.

## Linked entities

- **Chemicals:** dopamine (PubChem CID 681), dobutamine (PubChem CID 36811), methimazole (PubChem CID 1349907), propranolol (PubChem CID 4946)

## Full-text entities

- **Genes:** TSHR (thyroid stimulating hormone receptor) [NCBI Gene 7253] {aka CHNG1, LGR3, hTSHR-I}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}
- **Diseases:** pulmonary inflammation (MESH:D011014), microcephaly (MESH:D008831), NH (MESH:D006980), systemic (MESH:D015619), diarrhea (MESH:D003967), prematurity (MESH:C536271), hyperphagia (MESH:D006963), conduction block (MESH:D006327), Myocardial injury (MESH:D009202), bleeding (MESH:D006470), tachycardia (MESH:D013610), heart failure (MESH:D006333), pulmonary exudative (MESH:C536382), weight gain (MESH:D015430), rash (MESH:D005076), vomiting (MESH:D014839), hypoxia (MESH:D000860), systolic murmur (MESH:D054160), necrosis (MESH:D009336), hyperactivity (MESH:D006948), congenital goiter (MESH:D006042), erythema (MESH:D004890), acute respiratory distress (MESH:D012128), convulsions (MESH:D012640), exophthalmos (MESH:D005094), thyroid (MESH:D013966), cardiac abnormalities (MESH:D018376), preterm labor (MESH:D007752), growth retardation (MESH:D006130), mitochondrial dysfunction (MESH:D028361), intra cerebral hemorrhages (MESH:D002543), neutropenia (MESH:D009503), intellectual disability (MESH:D008607), hyperkalemia (MESH:D006947), fibrosis (MESH:D005355), crying (MESH:D003410), inflammation (MESH:D007249), trachea compression (MESH:D055090), anemia (MESH:D000740), tachypnea (MESH:D059246), heart murmurs (MESH:D006337), congenital heart disease (MESH:D006330), eyelid edema (MESH:D004487), cardiac insufficiency (MESH:D000309), cyanosis (MESH:D003490), cholestasis (MESH:D002779), thrombocytopenia (MESH:D013921), pulmonary exudative lesions (MESH:D008171), infection (MESH:D007239), SIRS (MESH:D018746), dyspnea (MESH:D004417), agitation (MESH:D011595), irritability (MESH:D001523)
- **Chemicals:** PTU (MESH:D011441), Ceftazidime (MESH:D002442), blood glucose (MESH:D001786), glucose (MESH:D005947), methimazole (MESH:D008713), dopamine (MESH:D004298), Oxygen (MESH:D010100), penicillin (MESH:D010406), dobutamine (MESH:D004280), cAMP (-), propranolol (MESH:D011433), bilirubin (MESH:D001663), lactate (MESH:D019344), catecholamines (MESH:D002395)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960539/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12960539/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960539/full.md

---
Source: https://tomesphere.com/paper/PMC12960539